Health Bulletin 21/September/2022

Published On 2022-09-21 11:48 GMT   |   Update On 2022-12-16 09:27 GMT
Advertisement

Here are the top health bulletin for the day:


DoP should be under Ministry of Health not Chemicals and Fertilizers: Parliamentary Panel

In order to resolve some of the major challenges being faced by the medical device manufacturers and to achieve better coordination, the Parliamentary Panel has recently recommended the Central Government that the Department of Pharmaceuticals (DoP) should be brought under the Ministry of Health and Family Welfare that presently falls under the Ministry of Chemicals and Fertilizers.

Advertisement

The department-related Parliamentary Committee for ministry of health and family welfare, in its report on 'Medical Devices: Regulation & Control' extensively examined the subject and identified key concern areas and challenges that are yet to be resolved.

For more details, check out the link given below:

DoP Should Be Under Ministry Of Health Not Chemicals And Fertilizers: Parliamentary Panel

Only 20 percent insurance money under PMGKP scheme got disbursed to kin of doctors died serving during COVID-19, reveals RTI

In a shocking revelation, a Right to Information Act (RTI) reply from New India Assurance Company Ltd. pointed out that the dependents of doctors, who died serving the nation in the Covid-19 battle, have received only 20% of the total money promised under Pradhan Mantri Garib Kalyan Package (PMGKP) Insurance Scheme.

Although the scheme ensured an insurance coverage of Rs 50 lakh each, the Insurance Company while replying to the RTI revealed on September 16 that as on August 31, the total number of beneficiaries under the PMGKP scheme was 1,962 and around Rs 981 crore has been disbursed for this purpose.

For more details, check out the link given below:

Only 20 Percent Insurance Money Under PMGKP Scheme Got Disbursed To Kin Of Doctors Died Serving During COVID-19, Reveals RTI

Relief To Bihar MBBS Interns: Cabinet Nod For Increasing Stipend To Rs 20,000 Per Month

In a major relief for the MBBS interns in Bihar, the State Cabinet has given its nod for the State Health Department's proposal for enhancing the amount of stipend from Rs 15,000 per month to Rs 20,000 per month.

This relief is not limited to the medical students only since the cabinet has approved increasing the internship amount to the junior doctors and staff belonging to the Government medical colleges, Dental Colleges and Ayurvedic colleges as well, adds HT.

For more details, check out the link given below:

Relief To Bihar MBBS Interns: Cabinet Nod For Increasing Stipend To Rs 20,000 Per Month

Study: Risk of bleeding decreases when people stop taking aspirin while on blood thinner

If you're already taking one blood thinner, mounting research suggests you might not need to take a second one.

In fact, when patients who are on a commonly prescribed blood thinner stop taking aspirin, their risk of bleeding complications drops significantly, a Michigan Medicine study finds.

Researchers analyzed over 6,700 people treated at anticoagulation clinics across Michigan for venous thromboembolism, or blood clots, as well as atrial fibrillation, an irregular heart rhythm that can cause stroke. Patients were treated with the common blood thinner warfarin but also took aspirin despite not having history of heart disease.

"We know that aspirin is not a panacea drug as it was once thought to be and can in fact lead to more bleeding events in some of these patients, so we worked with the clinics to reduce aspirin use among patients for whom it might not be necessary," said Geoffrey Barnes, M.D., senior author of the study and a cardiologist at the University of Michigan Health Frankel Cardiovascular Center.

Reference:

Schaefer JK, Errickson J, Gu X, et al. Assessment of an Intervention to Reduce Aspirin Prescribing for Patients Receiving Warfarin for Anticoagulation. JAMA Netw Open. 2022;5(9):e2231973. doi:10.1001/jamanetworkopen.2022.31973

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News